Advertisement

Topics

Drake Discusses CARMENA Trial and Emerging Approaches in RCC

16:28 EDT 12 Jul 2018 | OncLive

Charles G. Drake, MD, PhD, discusses the importance of the CARMENA results, the future of cytoreductive nephrectomy, and how the use of immunotherapy could change treatment in this setting.

Original Article: Drake Discusses CARMENA Trial and Emerging Approaches in RCC

NEXT ARTICLE

More From BioPortfolio on "Drake Discusses CARMENA Trial and Emerging Approaches in RCC"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...